| | | | | | | |

Improving Mesothelioma Chemotherapy with New Drug Delivery Method

ByAlex Strauss

asian doctorDelivering an encapsulated form of the chemotherapy drug pemetrexed (Alimta) directly into the pleural cavity where mesothelioma starts, may offer a more effective way to slow mesothelioma tumor growth.

Scientists in Japan have just added a new study to the growing body of research on liposomal pemetrexed, a form of pemetrexed that encloses molecules of the drug in tiny bubble-like structures called liposomes.

Liposomal Pemetrexed for Greater Impact, Fewer Side Effects

Although pemetrexed is the number one mesothelioma chemotherapy drug, only about four in ten malignant pleural mesothelioma patients respond to it.

Liposomal pemetrexed, on the other hand, allows more of the pemetrexed to get into mesothelioma tumors where it can do the most damage to the cancer cells without harming as many healthy cells.

The result is a more effective mesothelioma treatment with fewer toxic side effects.

Two Kinds of Mesothelioma Treatment Approaches

In the latest study of liposomal pemetrexed for mesothelioma treatment, researchers at Tokushima University tested versions of pemetrexed encapsulated in either a cholesterol-containing liposome or a cholesterol-free liposome.

Both kinds of pemetrexed were injected into the pleural cavities of mice infected with malignant pleural mesothelioma.

The team reports that the cholesterol-free version of pemetrexed “drastically inhibited the tumor growth in the pleural cavity” while uncoated or cholesterol-coated pemetrexed barely affected the mesothelioma tumors.

Why Liposomal Pemetrexed for Mesothelioma Chemotherapy?

The greatest challenge with any mesothelioma drug is how to kill as many cancer cells as possible while minimizing the impact on healthy cells. Although pemetrexed is an effective killer of mesothelioma cells, the high doses needed to achieve the most impact can cause deadly side effects.

The process of encapsulating a toxic chemotherapy drug like pemetrexed in a liposomal coating potentially creates a mesothelioma treatment that is both safer and more effective.

Targeted Drug Delivery Makes for More Effective Mesothelioma Treatment

Administering the liposomal pemetrexed directly into the pleural cavity ensures that more of the drug reaches its intended mesothelioma tumor target. The cholesterol-free pemetrexed not only stayed in the pleural cavity longer than other versions, but also released more of the drug.

“This therapeutic strategy of direct intrapleural administration of liposomal pemetrexed…might be a promising therapeutic approach to conquering the poor prognosis for malignant pleural mesothelioma,” writes study author Hidenori Ando of the Institute of Biomedical Sciences at Tokushima University.

The new study on mesothelioma treatment with liposomal pemetrexed appears in the Journal of Controlled Release.

Source:

Ando, H, et al, “Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed”, October 14, 2015, Journal of Controlled Release, Epub ahead of print

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    ByAlex Strauss

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…